Startups
Pioneering cellular medicines for women’s health
We’re developing off-the-shelf cell therapies for high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis.
Pioneering excellence in the field of immunotherapy Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers and endometriosis. We combine the best components of immune
We’re developing off-the-shelf cell therapies for high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis.
Pioneering excellence in the field of immunotherapy Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers and endometriosis. We combine the best components of immune
Overview
Location
Australia, Victoria, Melbourne
Total raised
$15M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 1, 2026 | Cartherics and Zucker Institute execute research collaboration and option agreement | Cartherics and Zucker Institute execute research collaboration and option agreement to combine iPSC-derived NK cell platform with novel anti-TF antibody MELBOURNE, AUSTRALIA, September 1, 2026 /EINPresswire.com/ -- Cartherics Pty Ltd (“Cart... |
| Jul 1, 2026 | Cartherics recognised as Asia Pacific Emerging Leader in Allogeneic Cell Therapy | We are proud of the team and technology platform that Cartherics has built over the past 10 years and delighted that it has been recognised with this award” — Dr Ian Nisbet, CEO, CarthericsMELBOURNE, VIC, AUSTRALIA, July 1, 2026 /EINPresswi... |
| Jun 10, 2026 | Cartherics strengthens global IP portfolio with Japanese patent grant | MELBOURNE, VIC, AUSTRALIA, June 10, 2026 /EINPresswire.com/ -- Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead progra... |
| Dec 18, 2025 | Cartherics to Participate in Prominent Biotech Investor Conferences During JPM Healthcare Week | • Dr Ian Nisbet, CEO, attending the RESI Investor Conference and BIO Partnering • Dr Vera Evtimov, Director of Operations, is presenting at Biotech Showcase MELBOURNE, VICTORIA, AUSTRALIA, December 18, 2025 /EINPresswire.com/ -- Cartherics ... |
| Oct 1, 2024 | Cartherics Raises Over $15 Million in Private Financing | Cartherics, a Melbourne, Australia-based biotechnology company developing immune cell therapies for the treatment of cancer and other diseases, raised over $15M in funding. Backers were not disclosed. The company intends to use the funds fo... |
| Oct 1, 2024 | Cartherics: Over $15 Million Secured To Develop Immune Cell Therapies For Treating Cancer | Cartherics, a biotechnology company developing immune cell therapies for treating cancer and other diseases, announced that it has raised well over its target AU$15 million in an oversubscribed financing round. This funding round will suppo... |
| Cartherics Pty Ltd | “Cartherics – The future of cancer treatment” |
Reviews 0
FAQ about Cartherics
How much funding has Cartherics raised?
Cartherics has raised $15M in total across 1 funding round.
What has the press written about Cartherics?
Parsers VC has collected 8 articles mentioning Cartherics, among them “Cartherics and Zucker Institute execute research collaboration and option agreement” (Sep 1, 2026) and “Cartherics recognised as Asia Pacific Emerging Leader in Allogeneic Cell Therapy” (Jul 1, 2026).
Is Cartherics still active?
Yes, Cartherics is active; its latest activity on Parsers VC dates from Nov 4, 2026.